TY - JOUR
T1 - Development of a Taiwan version of the eight-item morisky medication adherence scale and factors influencing patients' comprehension
AU - Lin, Yu Syuan
AU - Ho, Yih
AU - Hu, Chaur Jong
AU - Su, Wan Wen
AU - Hsu, Kuang Yang
AU - Shen, Winston W.
AU - Chiueh, Chuang Chin
AU - Yuan, Rey Yue
PY - 2013/4
Y1 - 2013/4
N2 - Objective: In Taiwan, patients' low adherence to medication needs immediate attention and rectification. This study was intended to evaluate patients' capability in comprehending a Mandarin- and Taiwanese-language Taiwan version of the eight-item Morisky Medication Adherence Scale (MMAS-8), and to explore the possible factors influencing patients' ability to understand. Methods: Sixty-five participants, recruited from the neurology clinics of two Taipei Medical University-affiliated hospitals, received semi-structured, one-on-one, in-depth interviews (using the Taiwan version of the MMAS-8 combined with open questions to ask the patients what they had heard and what their opinion was on the Taiwan version of the MMAS-8). A cross-sectional survey method was used to analyze the data. The original Taiwan version of the MMAS-8 was then modified according to the patients' and experts' opinion and was validated by expert review. Results: Lower comprehension of the response choices was related significantly to (1) age over 65 years (p <0.05), (2) education lasting less than 12 years (p <0.05), and (3) complex comorbid conditions (p <0.05). Many patients were confused by the dichotomous response choices in Question 1 to 7 and the wordings of Questions 2 and 8 of the original version of the Taiwan MMAS-8. Therefore, these were modified into more specified sentences according to patients' and experts' suggested opinion. Conclusion: The modified Taiwan version of the eight-item MMAS was validated by experts. Future research is needed to validate its psychometric properties.
AB - Objective: In Taiwan, patients' low adherence to medication needs immediate attention and rectification. This study was intended to evaluate patients' capability in comprehending a Mandarin- and Taiwanese-language Taiwan version of the eight-item Morisky Medication Adherence Scale (MMAS-8), and to explore the possible factors influencing patients' ability to understand. Methods: Sixty-five participants, recruited from the neurology clinics of two Taipei Medical University-affiliated hospitals, received semi-structured, one-on-one, in-depth interviews (using the Taiwan version of the MMAS-8 combined with open questions to ask the patients what they had heard and what their opinion was on the Taiwan version of the MMAS-8). A cross-sectional survey method was used to analyze the data. The original Taiwan version of the MMAS-8 was then modified according to the patients' and experts' opinion and was validated by expert review. Results: Lower comprehension of the response choices was related significantly to (1) age over 65 years (p <0.05), (2) education lasting less than 12 years (p <0.05), and (3) complex comorbid conditions (p <0.05). Many patients were confused by the dichotomous response choices in Question 1 to 7 and the wordings of Questions 2 and 8 of the original version of the Taiwan MMAS-8. Therefore, these were modified into more specified sentences according to patients' and experts' suggested opinion. Conclusion: The modified Taiwan version of the eight-item MMAS was validated by experts. Future research is needed to validate its psychometric properties.
KW - Colloquialism
KW - Medication adherence
KW - Medication compliance
KW - Taiwan version of the Morisky Medication Adherence Scale (Taiwan version of the MMAS)
KW - Taiwanese questionnaire
UR - http://www.scopus.com/inward/record.url?scp=84876100395&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876100395&partnerID=8YFLogxK
U2 - 10.1016/j.jecm.2013.02.005
DO - 10.1016/j.jecm.2013.02.005
M3 - Article
AN - SCOPUS:84876100395
SN - 1878-3317
VL - 5
SP - 77
EP - 80
JO - Journal of Experimental and Clinical Medicine(Taiwan)
JF - Journal of Experimental and Clinical Medicine(Taiwan)
IS - 2
ER -